title: Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration.
abstract: BACKGROUND
  Lentiviral vectors (LVs) can efficiently transduce a broad spectrum of cells and tissues, including dividing and non-dividing cells. So far the most widely used method for concentration of lentiviral particles is ultracentrifugation (UC).An important feature of vectors derived from lentiviruses and prototypic gamma-retroviruses is that the host range can be altered by pseudotypisation. The most commonly used envelope protein for pseudotyping is the glycoprotein of the Vesicular Stomatitis Virus (VSV.G), which is also essential for successful concentration using UC.
  
  
  RESULTS
  Here, we describe a purification method that is based on membrane adsorbers (MAs). Viral particles are efficiently retained by the anionic exchange MAs and can be eluted with a high-salt buffer. Buffer exchange and concentration is then performed by utilizing ultrafiltration (UF) units of distinct molecular weight cut off (MWCO). With this combined approach similar biological titers as UC can be achieved (2 to 5×10⁹ infectious particles (IP)/ml). Lentiviral particles from small starting volumes (e.g. 40 ml) as well as large volumes (up to 1,000 ml) cell culture supernatant (SN) can be purified. Apart from LVs, vectors derived from oncoretroviruses can be efficiently concentrated as well. Importantly, the use of the system is not confined to VSV.G pseudotyped lenti- and retroviral particles and other pseudotypes can also be purified.
  
  
  CONCLUSIONS
  Taken together the method presented here offers an efficient alternative for the concentration of lenti- as well as retroviral vectors with different pseudotypes that needs no expensive equipment, is easy to handle and can be used to purify large quantities of viral vectors within a short time.
authors: Institute of Pharmacology and Toxicology, Biomedical Center, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany.
authors: Katrin
authors: K
authors: Zimmermann
authors: Oliver
authors: O
authors: Scheibe
authors: Andreas
authors: A
authors: Kocourek
authors: Jutta
authors: J
authors: Muelich
authors: Elke
authors: E
authors: Jurkiewicz
authors: Alexander
authors: A
authors: Pfeifer
references: Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8033-7
references: 8396259
references: Methods Cell Biol. 1994;43 Pt A:99-112
references: 7823872
references: Hum Gene Ther. 2000 Mar 20;11(5):771-5
references: 10757356
references: Methods Mol Biol. 2009;530:391-405
references: 19266335
references: Hum Mol Genet. 2001 Dec 15;10(26):3075-81
references: 11751689
references: Gene Ther. 2005 Oct;12 Suppl 1:S36-50
references: 16231054
references: Hum Gene Ther. 2003 Apr 10;14(6):497-507
references: 12718761
references: Gene Ther. 2005 Oct;12 Suppl 1:S28-35
references: 16231053
references: J Biotechnol. 2007 Jan 10;127(3):520-41
references: 16950534
references: Nat Genet. 2000 Jun;25(2):217-22
references: 10835641
references: Biotechniques. 2003 May;34(5):1074-8, 1080
references: 12765034
references: Nat Med. 1995 Mar;1(3):275-7
references: 7585046
references: J Natl Cancer Inst. 1960 Apr;24:933-51
references: 14423465
references: J Virol. 2007 Jan;81(2):539-47
references: 17079284
references: Gene Ther. 2011 Jun;18(6):531-8
references: 21248790
references: J Virol. 1998 Nov;72(11):8463-71
references: 9765382
references: Biotechnol Bioeng. 2005 May 20;90(4):391-404
references: 15812800
references: J Virol. 2004 Sep;78(18):9820-7
references: 15331716
references: Virology. 2001 Feb 1;280(1):124-31
references: 11162826
references: Biotechnol Adv. 2006 May-Jun;24(3):321-37
references: 16448798
references: J Virol. 1996 Aug;70(8):5701-5
references: 8764092
references: Gene Ther. 2002 Dec;9(24):1708-14
references: 12457285
references: J Virol Methods. 2004 Dec 15;122(2):131-9
references: 15542136
references: Mol Ther. 2001 Apr;3(4):623-30
references: 11319925
references: Science. 1996 Apr 12;272(5259):263-7
references: 8602510
references: Virology. 2003 Mar 30;308(1):137-46
references: 12706097
references: Biotechnol Prog. 1999 Jan-Feb;15(1):1-11
references: 9933508
references: J Virol. 1996 Jan;70(1):217-22
references: 8523528
references: Nature. 2010 Sep 16;467(7313):318-22
references: 20844535
references: J Virol. 2004 Feb;78(3):1421-30
references: 14722297
references: Hum Gene Ther. 2003 Aug 10;14(12):1139-53
references: 12908966
references: Hum Gene Ther. 2004 Feb;15(2):221-6
references: 14975194
references: Mol Ther. 2001 Mar;3(3):319-22
references: 11273773
references: Curr Top Microbiol Immunol. 2002;261:75-105
references: 11892254
references: Annu Rev Biochem. 2005;74:711-38
references: 15952901
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jun 6;837(1-2):59-68
references: 16697280
references: Virology. 1997 Mar 31;230(1):134-44
references: 9126269
references: J Gene Med. 2008 Nov;10(11):1163-75
references: 18773500
references: Hum Gene Ther. 2010 Dec;21(12):1665-73
references: 20507233
references: Nat Protoc. 2009;4(4):495-505
references: 19300443
references: Adv Exp Med Biol. 1988;241:35-40
references: 3223411
references: BMC Biotechnol. 2009 Feb 16;9:10
references: 19220915